1. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukaemia;Berman;Blood,1991
2. Randomized multicenter trial of cytosine arabinoside with mitozantrone to daunorubicin in previously untreated adult patients with acute non-lymphocytic leukaemia (ANLL);Arlin;Leukaemia,1990
3. Meta-analysis of randomised trials of idarubicin (IDAR) or mitozantrone (MTO) versus daunorubicin (DNR) as induction therapy for acute myeloid leukaemia;Wheatley;Blood,1995
4. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council AML9 study;Rees;Br J Haematol,1996
5. A randomized study of high-dose cytarabine in induction in acute myeloid leukaemia;Bishop;Blood,1996